NRAS and melanoma: RAS oncogenes are driver genes in about 30% of melanoma cases, with NRAS being the dominant one, accounting for 25–28% of melanoma cases (Hodis et al. 2012; TCGA Network et al. 2015; Lokhandwala et al. 2019; Louveau et al. 2020).